Pharma Pulse 3/7/24: Antipsychotic Prescribing Patterns in Pediatric Patients with MDD, AI Hype Is a Two-Edged Sword & more

Image Credit: © nimito | AdobeStock_429594588.jpeg

Diversity in Clinical Trials: The Need to Take Action

Gadi Saarony, CEO of Advarra examines the current state of diversity in clinical research. He discusses the need for industry to take more action in making trials more diverse, what regulatory bodies need to do to increase awareness, and how researchers can best reach diverse populations.

Antipsychotic Prescribing Patterns in Pediatric Patients with Major Depressive Disorder

Findings emphasize the importance of further research on effective and safe alternative treatments for MDD in children and adolescents, specifically in patients who are refractory to nonpharmacologic treatment and/or standard of care antidepressants

Adobe Finds AI Hype Is a Two-Edged Sword

Competitive threat from OpenAI’s Sora tool is overblown, but rising valuation made its stock vulnerable

CMS To Assist Providers Squeezed By Ransomware Outage At Change

The Centers for Medicare and Medicaid Services announced processing and financial steps to help hospitals, health systems, and pharmacies to navigate continued disruptions at UnitedHealth subsidiary Change Healthcare. The company's network is still offline following a ransomware attack.

@HBAnet on Twitter/X:

HBA CEO @MaryEStutts will join an esteemed panel of #womenleaders at #SXSW to discuss how AI is driving progress in sectors like business, marketing, & #healthcare. Join the livestream from the @FemaleQuotient social channels. #HBAimpact #genderequality

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs